NDA[removed]S-026 NDA[removed]S-013 Page 3

First Page		Document Content
Date: 2009-03-31 15:16:32 Organofluorides Pyridines Bristol-Myers Squibb Cyclopropanes Efavirenz Antiretroviral drug Reverse-transcriptase inhibitor Nevirapine Atazanavir Chemistry Organic chemistry Non-nucleoside reverse transcriptase inhibitors		NDA[removed]S-026 NDA[removed]S-013 Page 3 Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 247,44 KB Share Document on Facebook

	Communication pubs.acs.org/JACS Highly Diastereo- and Enantioselective Synthesis of TriﬂuoromethylSubstituted Cyclopropanes via Myoglobin-Catalyzed Transfer of Triﬂuoromethylcarbene Antonio Tinoco, Viktoria Steck, Vi DocID: 1uSIY - View Document
	New Drugs Approved in FY 2015 Review Category Approval Date No. DocID: 1r3Vv - View Document
	Microsoft Word - GILEAD BRIEFING DocID: 1r2Vm - View Document
	Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases DocID: 1qOAQ - View Document
	Personalized Medicine Using genetic information to Help Fight Disease Personalized medicine is changing the way patients with Hepatitis C are treated…and cured.1 What is Personalized Medicine? DocID: 1qCC6 - View Document